Clinical Trial Update: Recombinant Human IL-4 Receptor Used in Treatment of Asthma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of a recombinant human IL-4 receptor for the treatment of asthma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Recombinant Human IL-4 Receptor (Interleukin-4 receptor)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Asthma | Phase 2 | Status: COMPLETED